1. Broadening the phenotypic spectrum of the presumably epilepsy-related SV2A gene variants.
- Author
-
Badura-Stronka M, Kuszel Ł, Wencel-Warot A, Cudnoch K, Wołyńska K, Rutkowska K, Steinborn B, and Płoski R
- Subjects
- Humans, Levetiracetam therapeutic use, Membrane Glycoproteins genetics, Nerve Tissue Proteins genetics, Genetic Variation, Arthrogryposis chemically induced, Epilepsy drug therapy, Epilepsy genetics, Epilepsy chemically induced
- Abstract
Missense variants in the synaptic vesicle glycoprotein SV2A gene have been previously found in a few individuals with epilepsy. Adverse reaction to levetiracetam in individuals with various variants of this gene has recently been described. Here, we report on a family with several members affected by epilepsy. In affected members of this family, we identified a variant in the SV2A gene (NM_014849.5: c.1978 G>A, p.(Gly660Arg). This family case further supports the role of the SV2A gene in autosomal dominant epilepsy. It provides new information on the course of epilepsy in people with variants in the SV2A gene who have never been treated with SV2A agonists and specific neurodevelopmental features of this syndrome., Competing Interests: Conflict of Interest The authors declare no conflict of interests., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF